Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) traded down 1.8% during trading on Wednesday . The stock traded as low as $0.57 and last traded at $0.57. 18,721 shares traded hands during trading, a decline of 99% from the average session volume of 1,286,615 shares. The stock had previously closed at $0.58.
Elevai Labs Stock Down 2.2 %
The stock has a 50 day moving average price of $0.70.
Elevai Labs (NASDAQ:ELAB – Get Free Report) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.08) earnings per share for the quarter. The firm had revenue of $0.70 million during the quarter.
Elevai Labs Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Read More
- Five stocks we like better than Elevai Labs
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Comprehensive Analysis of PayPal Stock
- What is a Dividend King?
- Intuitive Surgical Stock Can Trend Much Higher This Year
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
